MeiraGTx Holdings PLC Dividends
The next dividend date for MeiraGTx Holdings PLC has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for MeiraGTx Holdings PLC (MGTX)
More About MeiraGTx Holdings PLC
MeiraGTx Holdings plc, a clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also developing AAV-AQP1 in Phase 2 trial for radiation-induced grade 2/3 radiation-induced xerostomia, as well as in Phase ½ trial for Sjogren's syndrome; AAV-GAD in Phase 2 trial for Parkinson's disease; AAV-RPE65 in Phase 2 trial for RPE65-associated retinal dystrophy; and AAV-CNGB3 and AAV-CNGA3, which are both in Phase 2 trial for achromatopsia, as well as offers AAV-AIPL1 for Leber congenital amaurosis (LCA) 4. In addition, the company's products under preclinical development include AAV-RDH12 for retinol dehydrogenase 12 mutation-associated retinal dystrophy; AAV-BBS10 for Bardet-Biedl syndrome (BBS) due to BBS10 mutations; AAV-RetGC for LCA type 1; and AAV-UPF1 for amyotrophic lateral sclerosis, as well as programs for Alzheimer's disease, and wet and dry neovascular age related macular degeneration. Further, it provides riboswitch platform for the delivery of metabolic peptides; and cell therapies for oncology, autoimmune disease, and long term intractable pain. The company has collaborations with Johnson & Johnson Innovative Medicine for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease; and Hologen Limited for the research, development, manufacture, and commercialization of AAV-GAD investigational gene therapy for the treatment of Parkinson's disease, AAV-BDNF investigational gene therapy for genetic obesity disorders, and other genetic medicines to the central nervous system. MeiraGTx Holdings plc was founded in 2015 and is based in New York, New York.
Owning MeiraGTx Holdings PLC Stock on the Dividend Date
If you own MeiraGTx Holdings PLC stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of MeiraGTx Holdings PLC stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of MeiraGTx Holdings PLC stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying MeiraGTx Holdings PLC stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the MeiraGTx Holdings PLC dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More MeiraGTx Holdings PLC Dividends
You can contact us any time if you would like to ask questions about MeiraGTx Holdings PLC dividends or anything else related to the stock market.